BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17161439)

  • 1. Mutagenic potency of food-derived heterocyclic amines.
    Felton JS; Knize MG; Wu RW; Colvin ME; Hatch FT; Malfatti MA
    Mutat Res; 2007 Mar; 616(1-2):90-4. PubMed ID: 17161439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A QSAR for the mutagenic potencies of twelve 2-amino-trimethylimidazopyridine isomers: structural, quantum chemical, and hydropathic factors.
    Knize MG; Hatch FT; Tanga MJ; Lau EY; Colvin ME
    Environ Mol Mutagen; 2006 Mar; 47(2):132-46. PubMed ID: 16258923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSAR modelling for mutagenic potency of heteroaromatic amines by optimal SMILES-based descriptors.
    Toropov AA; Toropova AP; Benfenati E
    Chem Biol Drug Des; 2009 Mar; 73(3):301-12. PubMed ID: 19207466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and decomposition of an ester derivative of the procarcinogen and promutagen, PhIP, 2-amino-1-methyl-6-phenyl-1H-imidazo[4,5-b]pyridine: unusual nitrenium ion chemistry.
    Nguyen TM; Novak M
    J Org Chem; 2007 Jun; 72(13):4698-706. PubMed ID: 17542636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural and quantum chemical factors affecting mutagenic potency of aminoimidazo-azaarenes.
    Hatch FT; Colvin ME; Seidl ET
    Environ Mol Mutagen; 1996; 27(4):314-30. PubMed ID: 8665874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultimate carcinogenic metabolites from aromatic and heterocyclic aromatic amines: a computational study in relation to their mutagenic potency.
    Borosky GL
    Chem Res Toxicol; 2007 Feb; 20(2):171-80. PubMed ID: 17261035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative structure-activity (QSAR) relationships of mutagenic aromatic and heterocyclic amines.
    Hatch FT; Colvin ME
    Mutat Res; 1997 May; 376(1-2):87-96. PubMed ID: 9202742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended quantitative structure-activity relationships for 80 aromatic and heterocyclic amines: structural, electronic, and hydropathic factors affecting mutagenic potency.
    Hatch FT; Knize MG; Colvin ME
    Environ Mol Mutagen; 2001; 38(4):268-91. PubMed ID: 11774358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the o-acetylation reaction of hydroxylated heterocyclic amines by human arylamine N-acetyltransferases: a computational study.
    Lau EY; Felton JS; Lightstone FC
    Chem Res Toxicol; 2006 Sep; 19(9):1182-90. PubMed ID: 16978022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic QSAR of aromatic amines: new models for discriminating between homocyclic mutagens and nonmutagens, and validation of models for carcinogens.
    Benigni R; Bossa C; Netzeva T; Rodomonte A; Tsakovska I
    Environ Mol Mutagen; 2007 Dec; 48(9):754-71. PubMed ID: 18008355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic nitrenes/nitrenium ions from azido-imidazoarenes and their structure-activity relationships.
    Wild D; Dirr A
    Mutagenesis; 1989 Nov; 4(6):446-52. PubMed ID: 2695757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two food-borne heterocyclic amines: metabolism and DNA adduct formation of amino-alpha-carbolines.
    Frederiksen H
    Mol Nutr Food Res; 2005 Mar; 49(3):263-73. PubMed ID: 15704238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinogenic carbocyclic and heterocyclic aromatic amines: a DFT study concerning their mutagenic potency.
    Borosky GL
    J Mol Graph Model; 2008 Nov; 27(4):459-65. PubMed ID: 18799337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ames test and antitumor activity of 1-(X-phenyl)-3,3-dialkyltriazenes. Quantitative structure-activity studies based upon molecular shape analysis.
    Hopfinger AJ; Potenzone R
    Mol Pharmacol; 1982 Jan; 21(1):187-95. PubMed ID: 7132958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The food-derived heterocyclic amines and breast cancer: a 1995 perspective.
    Synderwine EG
    Recent Results Cancer Res; 1996; 140():17-25. PubMed ID: 8787060
    [No Abstract]   [Full Text] [Related]  

  • 16. A quantitative structure-activity relationship (QSAR) study of mutagenicity in several series of organic chemicals likely to be activated by cytochrome P450 enzymes.
    Lewis DF; Ioannides C; Parke DV
    Teratog Carcinog Mutagen; 2003; Suppl 1():187-93. PubMed ID: 12616608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of heterocyclic aromatic amines in oil under storage and frying conditions and reduction of their mutagenic potential.
    Randel G; Balzer M; Grupe S; Drusch S; Kaina B; Platt KL; Schwarz K
    Food Chem Toxicol; 2007 Nov; 45(11):2245-53. PubMed ID: 17619072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of the mutagenicity of heterocyclic amines formed during the cooking processes.
    Zhang YP; Klopman G; Rosenkranz HS
    Environ Mol Mutagen; 1993; 21(1):100-15. PubMed ID: 8419150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Structural basis of mutagenicity of heterocyclic amines].
    Fu ZD
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):101-4. PubMed ID: 8354105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the structural requirements for mutagencitiy, by incorporating molecular flexibility and metabolic activation of chemicals. II. General Ames mutagenicity model.
    Serafimova R; Todorov M; Pavlov T; Kotov S; Jacob E; Aptula A; Mekenyan O
    Chem Res Toxicol; 2007 Apr; 20(4):662-76. PubMed ID: 17381132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.